Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study (REDUCE PAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03821129
Recruitment Status : Recruiting
First Posted : January 29, 2019
Last Update Posted : August 12, 2021
Sponsor:
Information provided by (Responsible Party):
W.L.Gore & Associates

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2026
Estimated Study Completion Date : December 2029